Puremhc
Austin, US · 1 known investors
Pure MHC discovers HLA Class I and Class II peptide targets for immunotherapies targeting cancer, infectious disease, and autoimmune diseases using the sHLA platform technology.
Founders & leadership
DW
Dr. William HildebrandChief Scientist at Pure MHC and Research Professor in the OU Department of Microbiology and Immunology
Board
TA
Thomas A. HarlanCEO of Emergent Technologies, Inc.
Investors · 1
Frequently asked questions
- What does Puremhc do?
- Pure MHC discovers HLA Class I and Class II peptide targets for immunotherapies targeting cancer, infectious disease, and autoimmune diseases using the sHLA platform technology.
- Who are Puremhc's investors?
- Puremhc's investors include Emergent Technologies, Inc..
- Where is Puremhc headquartered?
- Puremhc is headquartered in Austin, US.